News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Mohamed Benlazar: Ziftomenib with venetoclax/azacitidine in R/R AML with NPM1 mutations or KMT2A rearrangements
Photo from Mohamed Benlazar/X
Dec 11, 2024, 11:32

Mohamed Benlazar: Ziftomenib with venetoclax/azacitidine in R/R AML with NPM1 mutations or KMT2A rearrangements

Mohamed Benlazar, Professor of Hematology at Sidi Bel Abbès University Hospital, shared a post on X:

“Ziftomenib combined with venetoclax/azacitidine in patients with R/R AML with NPM1 mutations or KMT2A rearrangements.”

Mohamed Benlazar: Ziftomenib with venetoclax/azacitidine in R/R AML with NPM1 mutations or KMT2A rearrangements

 

cancer Mohamed Benlazar OncoDaily Oncology
Special Coverage
Blog
Feb 21, 2025, 15:06
The full press release of ELLOK is out
Blog
Feb 21, 2025, 14:59
Siobhan Freeney: What women in Ireland need to know about Dense Breasts and Cancer
Blog
Feb 21, 2025, 14:54
CEO of the Canadian Cancer Society about the inequities in cancer care across populations in Canada - UICC
Career
Feb 21, 2025, 14:34
Kristiyana Kaneva is appointed as Medical Director of Oncology Early Development at AbbVie
Blog
Feb 21, 2025, 14:27
Douglas Flora: A Cure for Cancer - Closer Than We Think?
Blog
Feb 21, 2025, 14:26
14th Biennial Childhood Leukemia and Lymphoma Symposium: Advancing Research and Collaboration in Budapest
Blog
Feb 21, 2025, 14:13
Rachel Chown: An incredibly inspiring and humbling talk from Liubov Lisovska
Science
Feb 21, 2025, 14:08
Survival improvement of patients with melanoma brain or leptomeningeal metastases in Denmark - CCIT-DK
Science
Feb 21, 2025, 13:51
Aaron Sverdlov: Identifying common pathways for doxorubicin and carfilzomib-induced cardiotoxicities
Blog
Feb 21, 2025, 13:40
Breaking barriers: ensuring equal cancer care access for diverse communities - SPCC
Blog
Feb 21, 2025, 13:29
Sana Al Sukhun: Enjoyed joining Emirates Oncology Society's SABCS
Blog
Feb 21, 2025, 13:28
Targeted protein degradation is changing the landscape of cancer treatment - The ICR